BofA Finance LLC has announced the filing of a pricing supplement for its new financial product, the Contingent Income Buffered Auto-Callable Yield Notes. This filing, dated November 4, 2026, is significant as it represents the company's efforts to expand its product offerings in the competitive national commercial banking sector.
The new yield notes are linked to the S&P 500 Futures 40% Volatility Compass TCA 6% Decrement Index ER. They are designed to provide investors with contingent income based on the performance of the underlying index. The notes are expected to price on November 13, 2026, and will be issued on November 18, 2026.
According to the filing, the notes will have a term of approximately five years, unless called prior to maturity. Payments on the notes will depend on the performance of the underlying index, with a contingent coupon rate expected to range between 10.25% and 11.25% per annum.
The filing states, "Payments on the Notes will depend on the performance of the S&P 500 Futures 40% Volatility Compass TCA 6% Decrement Index ER." This highlights the potential risks and rewards associated with the investment, as the notes will not be listed on any securities exchange and are subject to the credit risk of BofA Finance LLC as the issuer.
BofA Finance LLC, classified under the SIC code 6021 for National Commercial Banks, is a subsidiary of Bank of America Corporation. The company is based in Charlotte, North Carolina, and operates under the EIN 813167494. The filing includes multiple recent submissions, indicating an active engagement in the capital markets.
The filing does not specify what happens next, but the anticipated pricing and issuance of these notes could impact investor interest and competitive dynamics within the national commercial banking sector.
Read Next
Stryker Corp files registration statement for new securities
Citigroup files preliminary pricing supplement for notes
Pitofsky files to sell 180 shares of Regeneron Pharmaceuticals
Guild Capital - Project C SPV LLC raises $12.5 million in offering
Co-Diagnostics registers 39.6 million shares for sale
Fraga Francisco Files to Sell 600 Shares of McKesson Corp










